What Are the Benefits of Turmeric? Trials, Doses and Cautions

Turmeric is the ground rhizome of Curcuma longa, a plant in the ginger family; its yellow compounds, the curcuminoids, are a few per cent of the powder (pure turmeric powders averaged 3.14% curcumin in one analysis), and nearly all the trial evidence is for standardised extracts. Across 23 trials and 2,175 people, curcumin reduced knee osteoarthritis pain by about 1.6 points of 10 against placebo, with about half the odds of side effects seen on anti-inflammatory painkillers; it lowers inflammation markers, and blood-sugar markers in prediabetes and type 2 diabetes, by small amounts; and in diagnosed depression it improved symptoms more than placebo in small trials, an effect a 2026 review judged fragile.^{1, 2, 3, 4, 5, 6} None of that is an authorised health claim in Great Britain, the trials are short and mostly small, and rare liver injury has been reported with turmeric supplements, including high-dose, high-absorption products in an Italian series.^{7, 8, 9}

Sources checked on 1 November 2026.

What is turmeric?

Turmeric is the dried, ground rhizome of Curcuma longa, a ginger-family plant grown mostly in India. It is not ginger (Zingiber officinale), a different plant with different compounds. The yellow comes from three related pigments, curcumin, demethoxycurcumin and bisdemethoxycurcumin, which make up a few per cent of the powder by weight: pure turmeric powders averaged 3.14% curcumin in a laboratory analysis of 28 spice products, while curry powders held small and variable amounts.¹ A "95% extract" is turmeric with everything else stripped away, so a 500 mg capsule of 95% extract carries about 475 mg of curcuminoids and a 500 mg spice capsule about 16 mg of curcumin at that average; the food colour E100 is curcumin, and India supplies over 90% of the world's turmeric.¹⁰ "Tumeric" is simply the commonest misspelling.

What does turmeric do in the body?

Less than the pigment suggests, unless something helps it in. Plain curcumin is barely absorbed: 2 g taken alone gave undetectable or very low blood levels in volunteers, because the gut wall and liver convert it quickly.¹¹ The same 1998 study is the source of the "2,000%" figure on black-pepper products: 20 mg of piperine raised bioavailability by 2,000%, with higher blood levels from 15 minutes to an hour after the dose.¹¹ In laboratory tests piperine also blocks the liver enzyme CYP3A4 and the transporter P-glycoprotein that many medicines rely on, so pepper-containing products are worth a word with your pharmacist.¹² Across 66 trials, curcumin lowered C-reactive protein by about 0.6 mg/L and the cytokines IL-6 and TNF-alpha by small amounts in adults; these are blood markers, not symptoms.³ Two effects are physical: curcumin contracts the gallbladder at doses as small as 20 mg, and because so little is absorbed, yellow stools are among the effects reported in trials, which is also why people ask whether turmeric can change the colour of your urine.^{13, 14}

Is turmeric good for you?

As a spice it is food; as a supplement, the answer is by outcome: moderate evidence for short-term knee osteoarthritis pain, small but consistent changes in blood markers, a fragile benefit in diagnosed depression, and nothing usable for cancer, Alzheimer's, weight or skin ageing. Turmeric and curcumin have no authorised health claim in Great Britain: the botanical claims submitted in 2008 were never assessed and remain "on hold", a statement about the register rather than a verdict on the evidence.⁷ In 2017 the UK advertising regulator upheld complaints against a press advertisement claiming a turmeric supplement "supports healthy joints": trials in people with osteoarthritis, it ruled, did not show that turmeric would support healthy joints in people without arthritis.¹⁵ The NHS website has no page on turmeric; the UK's expert safety statement is the Committee on Toxicity's December 2024 statement on liver injury, covered below, and NHS Wales's medicines advice service publishes guidance for pharmacists.^{10, 14}

Does turmeric help joint pain?

Curcuminoid extracts reduced knee osteoarthritis pain and improved function more than placebo in short trials, by about 1.6 points of 10 in the largest analysis (23 trials, 2,175 people), and the limits come in the same breath: the trials are short, mostly small and mostly Asian, and one review found curcuminoids less effective than ibuprofen.^{2, 8} In the largest head-to-head trial, 1,500 mg a day of a turmeric extract matched 1,200 mg of ibuprofen over four weeks in 367 people, with fewer stomach complaints.¹⁶ An Australian placebo-controlled trial (70 people, 12 weeks, part-funded by the extract's manufacturer) found a modest 9 mm reduction on a 100 mm pain scale and no change in joint swelling or cartilage composition on MRI, so no structural effect has been shown.¹⁷ Doses of 1,000 mg a day or more relieved knee pain no better than lower doses.¹⁸ Turmeric is never a substitute for a prescribed anti-inflammatory, steroid or disease-modifying medicine. How to take turmeric for inflammation sets the trials out by type of arthritis; how long turmeric takes to work explains the 8 to 12 week fair trial.

Does turmeric help with mood, sleep or memory?

In diagnosed major depression, curcumin extract at 500 or 1,000 mg a day for 12 weeks improved symptoms more than placebo in a trial of 123 people, and a 2026 review of 19 trials found a pooled benefit that it judged fragile, with very wide disagreement between trials.^{5, 6} Trials in healthy adults are few and small, so there is no basis for a "mood boost", and we found no human trial showing that it "releases serotonin" or with sleep as its main outcome. In Alzheimer's disease the pooled trend across small trials was towards worse scores than placebo, so no memory or dementia statement is possible.¹⁹

Is turmeric good for your heart, blood sugar or digestion?

Heart: the British Heart Foundation's position is that there is no strong evidence that turmeric supplements are good for your heart, because study findings vary.²⁰ In 12 to 16 trials per measure in adults with metabolic disease, turmeric and curcuminoids lowered triglycerides by about 0.22 mmol/L and LDL cholesterol by about 0.25 mmol/L, with wide variation between trials; these are blood fats, not heart attacks, and nothing "cleans arteries".²¹ Blood sugar: in 34 trials in prediabetes and type 2 diabetes, curcumin lowered HbA1c by about 0.3 percentage points and fasting glucose by about 0.56 mmol/L, more so at 1 g a day or more; this is trial evidence, not a reason to change any medicine.⁴ Weight: across 31 trials the pooled change was under 1 kg, too small to support belly-fat claims.²² Digestion: turmeric has no authorised digestive claim; in one knee trial people on curcumin reported less wind than people on diclofenac, and at supplement doses the commonest effects are themselves digestive: diarrhoea, nausea, reflux and indigestion.^{23, 14} Registered herbal medicines are a separate matter under medicines law: the European Union herbal monograph accepts turmeric root, on long-standing use rather than trial evidence, for the relief of digestive disturbances such as fullness, slow digestion and wind, at 0.5 to 1 g of powdered root two to three times a day for adults.²⁴

What does turmeric do to the female body?

Mostly the same as to anyone else; the sex-specific evidence is in two conditions. In polycystic ovary syndrome (PCOS, now called polyendocrine metabolic ovarian syndrome or PMOS by the NHS), seven trials in 447 women found curcumin lowered fasting glucose, insulin resistance (HOMA-IR −0.57), total cholesterol and CRP by modest amounts, with no excess of side effects.²⁵ For period pain and premenstrual symptoms, a 2025 systematic review found ten randomised trials, six reporting fewer symptoms on curcumin; a 2024 meta-analysis was retracted by its journal in 2025, so the size of any effect is unsettled.^{26, 27} Menopausal joint aches come up often, and we found no trial of turmeric for them; menopause joint pain: what actually helps covers what has been tested. Studies of curcumin in pregnancy have been in animals only, so supplement doses have no human safety data in pregnancy, and we found none for breastfeeding; the spice in cooking is normal food.²⁸ On HRT, NHS Wales's medicines advice service advises caution because curcumin can displace oestrogen from its receptors in laboratory tests, and caution with hormone-sensitive conditions because turmeric may have weak oestrogen-like actions; on tamoxifen, curcumin lowered levels of its active form in women with breast cancer.^{29, 14, 30} The medicine-by-medicine table is linked below.

How much turmeric is a sensible amount?

Three figures replace the circulating numbers.

The acceptable daily intake, set for curcumin as a food colour, is not a supplement limit: the UK Committee on Toxicity questioned whether it fits supplements formulated for better absorption, found that 2 of 15 UK supplements surveyed in 2021 would exceed it at the label dose, and noted liver injury in rare people below it.^{31, 10} The trial band comes from the knee and depression trials.^{16, 5, 18} Mg of powder, mg of extract and mg of curcuminoids are three different numbers on a label. How much turmeric a day works through the conversion; how to take turmeric covers food, fat, timing and reading a label.

Is turmeric safe, and who should not take it?

The commonest effects at supplement doses are nausea, reflux, cramps and loose stools; what are the side effects of turmeric opens with those and carries the liver position in full.

Liver. Rare cases of liver injury have been reported with turmeric or curcumin supplements: ten US cases over 18 years, mostly women, typically one to four months in, one death; seven of the ten carried the immune gene variant HLA-B*35:01, which makes up about 6% of gene copies in the general population, and the UK Committee on Toxicity calls the reaction idiosyncratic: rare, unpredictable and possible below the acceptable daily intake.^{32, 10} In Tuscany all seven cases involved high-dose, high-absorption products; in the US series piperine was present in three of the seven products tested; and liver tests normalised in every one of an 11-case pathology series once the supplement was stopped.^{9, 32, 33} The committee concluded in December 2024 that, despite limited data, there is reasonable evidence for a link, because the injuries appeared on taking the supplement and reversed on stopping, and that contamination was an unlikely cause.¹⁰ Australia's medicines regulator, the Therapeutic Goods Administration, had received 18 reports of liver problems in people taking turmeric or curcumin products up to 29 June 2023; in four of them no other ingredient was likely to have contributed, and two of those four were severe, one fatal. It judged the risk rare, possibly higher with enhanced-absorption or higher-dose products, and not apparent with turmeric eaten in typical food amounts.³⁴ Against that, trials have not reported liver toxicity, and in fatty liver disease one analysis of 15 trials found curcumin lowered the liver enzymes ALT and AST slightly, while another of 15 trials found lower AST but no change in ALT.^{35, 36, 37} Stop and seek medical advice the same day for dark urine, pale stools, yellow skin or eyes or abdominal pain; NHS Wales's medicines advice service advises avoiding turmeric and curcumin with liver disease or cholangitis, and anyone on methotrexate or another liver-processed medicine asks their team first.^{35, 38, 14}

Gallstones. Curcumin contracted the gallbladder by about 30% within two hours at 20 mg, and NHS Wales's medicines advice service advises avoiding turmeric and curcumin with gallstones or any biliary disease, since extracts can trigger biliary colic.^{13, 14}

Anticoagulants and antiplatelets. Curcumin reduces platelet stickiness in the laboratory; in an uncontrolled human study, ten days of a curcumin formulation changed neither INR on warfarin nor bleeding time on aspirin or clopidogrel, though a raised INR has been reported in a person on warfarin who started a turmeric product.^{39, 40, 29} "Blood thinner" is therefore a caution for your anticoagulant clinic or pharmacist, never a benefit; the firmer concern is piperine with CYP3A4 medicines, and medicinal turmeric is stopped at least two weeks before planned surgery.^{12, 14}

Iron. One man taking about 3.2 g of turmeric extract a day developed iron-deficiency anaemia that resolved when he stopped, while a single 500 mg dose of a formulated curcumin did not blunt iron absorption from iron tablets in 155 adults, in a trial funded by the formulation's supplier; if you take iron for anaemia, tell your GP.^{41, 42} The medicine-by-medicine table in UK generic names is on who should not take turmeric.

What do turmeric capsules and gummies give you?

A measured dose of curcuminoids, which the spice jar cannot: that is the benefit of a supplement, a dose rather than an outcome, and whatever the form, the curcuminoid figure on the label is the thing to read; in a 2026 survey of 125 turmeric supplements, 34% did not state it.⁴³ Gummies suit the reader who has decided to try a turmeric extract and would rather not swallow a capsule; the cautions on this page apply to every form.

What we don't know

• Long-term use: the largest long trial ran nine months in 240 adults with prediabetes; nothing has run for years.⁴⁴
• Who will react: the liver reaction is idiosyncratic; carriers of HLA-B*35:01 may be more susceptible, but no one can know in advance.¹⁰
• Whether better absorption means better results: a 2025 analysis of 17 knee trials found plain and absorption-enhanced preparations both reduced pain against placebo, at low certainty, without settling which is better.⁴⁵
• Depression: the pooled benefit is fragile and the trials disagree widely.⁶

Frequently asked questions

What are the top 10 benefits of turmeric?

The circulating lists of ten or thirty are mostly laboratory and animal findings presented as human results. The trials support a short list: less knee osteoarthritis pain in short trials, small changes in inflammation, blood-sugar and lipid markers, and a fragile benefit in diagnosed depression.^{2, 3, 4, 21, 6} Cancer, Alzheimer's, weight and skin ageing are not on it.^{19, 22}

What organ is turmeric good for?

No organ, in the sense meant; its measurable effects are on joint pain and blood markers. For the liver, fatty-liver trials show slightly lower enzymes in one analysis and rare case reports show injury, so "good for the liver" and "bad for the liver" are both the wrong summary.^{36, 32}

Can I just sprinkle turmeric on my food, and is raw turmeric better?

Yes. A teaspoon gives roughly 95 to 125 mg of curcumin at the average measured in pure powders, a food amount within the acceptable daily intake; we found no study showing that fresh or raw root is stronger. Black pepper's piperine raised curcumin's blood levels for about an hour in the 1998 study.^{1, 10, 11} Drinks follow the same arithmetic: turmeric shots, golden milk and turmeric tea work out the curcumin in each.

Is it OK to take turmeric every day?

Most positive trials ran 4 to 12 weeks, the longest well-known one nine months, and none has run for years.^{16, 17, 44} Daily use is reasonable with none of the cautions above, taken with a meal and with the liver symptoms in mind; is curcumin safe to take daily covers every-day and long-term use.

Sources

1. Tayyem RF, Heath DD, Al-Delaimy WK, Rock CL. Curcumin content of turmeric and curry powders. Nutrition and Cancer, 2006. Laboratory analysis of 28 spice products; funding not stated on PubMed. PubMed 17044766.
2. Zhao J, et al. Efficacy and safety of curcumin therapy for knee osteoarthritis: a Bayesian network meta-analysis. Journal of Ethnopharmacology, 2024. Network meta-analysis, 23 trials, 2,175 people; no competing interests declared, funding not stated on PubMed. PubMed 38036015.
3. Dehzad MJ, et al. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: a GRADE-assessed systematic review and dose-response meta-analysis. Cytokine, 2023. Meta-analysis, 66 randomised trials; no competing interests declared, funding not stated on PubMed. PubMed 36804260.
4. Bahari H, et al. Curcumin/turmeric supplementation on glycemic control in adults with prediabetes and type 2 diabetes: a systematic review and dose-response meta-analysis. Food Science and Nutrition, 2026. Meta-analysis, 34 trials; no conflicts declared, funding not stated on PubMed. PubMed 42005325.
5. Lopresti AL, Drummond PD. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: a randomised, double-blind, placebo-controlled study. Journal of Affective Disorders, 2017. Randomised placebo-controlled trial, 123 people, 12 weeks; funding not stated on PubMed. PubMed 27723543.
6. Musazadeh V, et al. Efficacy of curcumin in depression: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Annals of General Psychiatry, 2026. Meta-analysis, 19 trials; no competing interests declared, funding not stated on PubMed. PubMed 42472817.
7. Department of Health and Social Care. Great Britain nutrition and health claims (NHC) register. Official register. gov.uk.
8. Onakpoya IJ, et al. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. International Journal of Rheumatic Diseases, 2017. Meta-analysis, 7 trials, 797 people, all in Asia; funding not stated on PubMed. PubMed 28470851.
9. Lombardi N, et al. Acute liver injury following turmeric use in Tuscany: an analysis of the Italian Phytovigilance database and systematic review of case reports. British Journal of Clinical Pharmacology, 2021. Case analysis, 7 people, and systematic review of 23 published cases; funding not stated on PubMed. PubMed 32656820.
10. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Statement on the potential risk to human health of turmeric and curcumin supplements (COT/2024/07), summary and conclusions, December 2024. Expert committee statement, including a 2021 survey of 15 UK supplements; read in the UK Government Web Archive, as the committee's own site has withdrawn the page. webarchive.nationalarchives.gov.uk.
11. Shoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 1998. Pharmacokinetic study in rats and healthy volunteers, single doses; funding not stated on PubMed. PubMed 9619120.
12. Bhardwaj RK, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics, 2002. Laboratory study in human gut cells and liver microsomes; funding not stated on PubMed. PubMed 12130727.
13. Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Alimentary Pharmacology and Therapeutics, 1999. Randomised double-blind crossover trial, 12 healthy volunteers, single dose; funding not stated on PubMed. PubMed 10102956.
14. Welsh Medicines Advice Service (NHS Wales). Turmeric: potential adverse effects. Professional guidance, published 22 October 2024. wmic.wales.nhs.uk.
15. Advertising Standards Authority. Ruling A17-384506 on a press advertisement for a turmeric food supplement, complaints upheld, 25 October 2017. Regulator ruling; search the reference on the asa.org.uk rulings page.
16. Kuptniratsaikul V, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging, 2014. Randomised non-inferiority trial, 367 people, 4 weeks; funding not stated on PubMed. PubMed 24672232.
17. Wang Z, et al. Effectiveness of Curcuma longa extract for the treatment of symptoms and effusion-synovitis of knee osteoarthritis: a randomized trial. Annals of Internal Medicine, 2020. Randomised placebo-controlled trial, 70 people, 12 weeks; funded by the University of Tasmania and the extract's manufacturer. PubMed 32926799.
18. Hsiao AF, et al. The efficacy of high- and low-dose curcumin in knee osteoarthritis: a systematic review and meta-analysis. Complementary Therapies in Medicine, 2021. Meta-analysis, 11 trials, 1,258 people; funding not stated on PubMed. PubMed 34537344.
19. Zhu LN, et al. Curcumin intervention for cognitive function in different types of people: a systematic review and meta-analysis. Phytotherapy Research, 2019. Meta-analysis, 6 trials, 289 people; Chinese provincial research funding. PubMed 30575152.
20. British Heart Foundation. Should I be taking turmeric supplements? Heart Matters, answered by a BHF dietitian, page updated 22 August 2025. Charity guidance. bhf.org.uk.
21. Yuan F, et al. A systematic review and meta-analysis of randomized controlled trials on the effects of turmeric and curcuminoids on blood lipids in adults with metabolic diseases. Advances in Nutrition, 2019. Meta-analysis, 12 to 16 trials per outcome; funding not stated on PubMed. PubMed 31212316.
22. Sun Z, et al. The effects of curcumin on anthropometric and cardiometabolic parameters of patients with metabolic related diseases: a systematic review and dose-effect meta-analysis. Critical Reviews in Food Science and Nutrition, 2023. Meta-analysis, 31 trials; funding not stated on PubMed. PubMed 35475714.
23. Shep D, et al. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Trials, 2019. Randomised open-label trial, 139 people, 28 days; no competing interests declared. PubMed 30975196.
24. European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Curcuma longa L., rhizoma (EMA/HMPC/329755/2017), final, adopted 25 September 2018. Monograph (traditional use). ema.europa.eu.
25. Shen W, et al. Therapeutic effect and safety of curcumin in women with PCOS: a systematic review and meta-analysis. Frontiers in Endocrinology, 2022. Meta-analysis, 7 trials, 447 women; no commercial conflicts declared, funding not stated on PubMed. PubMed 36387924.
26. Shrateh ON, et al. Curcumin, a bioactive supplement for premenstrual syndrome and dysmenorrhea: a systematic review of randomised clinical trials. European Journal of Obstetrics and Gynecology and Reproductive Biology: X, 2025. Systematic review, 10 trials; no competing interests declared. PubMed 41281701.
27. Sharifipour F, et al. Effect of curcumin on dysmenorrhea and symptoms of premenstrual syndrome: a systematic review and meta-analysis. Korean Journal of Family Medicine, 2024. Meta-analysis, retracted by the journal in March 2025; cited only to record the retraction. PubMed 38266637.
28. Tossetta G, et al. The multifaced actions of curcumin in pregnancy outcome. Antioxidants, 2021. Narrative review; pregnancy studies in animals only; no conflicts declared. PubMed 33477354.
29. Welsh Medicines Advice Service (NHS Wales). Turmeric: potential interactions. Professional guidance, published 22 October 2024. wmic.wales.nhs.uk.
30. Hussaarts KGAM, et al. Impact of curcumin (with or without piperine) on the pharmacokinetics of tamoxifen. Cancers, 2019. Pharmacokinetic study in women with breast cancer; Dutch charitable foundation funding, no conflicts declared. PubMed 30909366.
31. EFSA Panel on Food Additives and Nutrient Sources added to Food. Scientific opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA Journal, 2010. Regulatory safety opinion. doi.org/10.2903/j.efsa.2010.1679.
32. Halegoua-DeMarzio D, et al. Liver injury associated with turmeric, a growing problem: ten cases from the Drug-Induced Liver Injury Network. American Journal of Medicine, 2023. Case series, 10 people, US network cases 2004 to 2022; US National Institutes of Health funding. PubMed 36252717.
33. Papke DJ, et al. Turmeric supplement-associated hepatitis: a clinicopathological series of 11 cases. Histopathology, 2025. Case series, 11 people; funding not stated on PubMed. PubMed 39381846.
34. Therapeutic Goods Administration (Australia). Medicines containing turmeric or curcumin: risk of liver injury. Regulator alert (safety advisory), published 15 August 2023, covering reports received up to 29 June 2023. tga.gov.au.
35. Akhtar N, et al. Rarely reported cases of hepatotoxicity associated with turmeric- and curcuminoid-containing dietary supplements: a comprehensive review by USP. Pharmaceutical Biology, 2026. Expert committee safety review (US Pharmacopeia); no conflicts declared. PubMed 42364655.
36. Vajdi M, et al. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis. Nutrition Reviews, 2025. Meta-analysis, 15 trials, 905 people; university research funding. PubMed 38213188.
37. Aragón-Vela J, et al. Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease? A systematic review, meta-analysis, and meta-regression. Phytotherapy Research, 2024. Meta-analysis, 15 trials, 835 people; Spanish government research funding. PubMed 38965866.
38. NHS. Jaundice. Page last reviewed 22 January 2024. nhs.uk/conditions/jaundice.
39. Hussain Y, et al. Regulatory effects of curcumin on platelets: an update and future directions. Biomedicines, 2022. Narrative review of laboratory and animal studies; no conflicts declared. PubMed 36551934.
40. Hu S, et al. Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin. European Review for Medical and Pharmacological Sciences, 2018. Uncontrolled before-and-after study in patients on each medicine, 10 to 15 days; funding not stated on PubMed. PubMed 30070343.
41. Smith TJ, Ashar BH. Iron deficiency anemia due to high-dose turmeric. Cureus, 2019. Case report, 1 person; no competing interests declared. PubMed 30899609.
42. Lorinczova HT, et al. Acute administration of bioavailable curcumin alongside ferrous sulphate supplements does not impair iron absorption in healthy adults in a randomised trial. Nutrients, 2021. Randomised placebo-controlled trial, 155 adults, single dose; funded by the curcumin formulation's supplier. PubMed 34371810.
43. Rahim-Mahdy H, Seifert R. A market and risk assessment of 125 turmeric supplements available in Australia, Germany, India, UK, and USA. Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Label survey of 125 products in five countries; no conflicts declared. PubMed 40773013.
44. Chuengsamarn S, et al. Curcumin extract for prevention of type 2 diabetes. Diabetes Care, 2012. Randomised placebo-controlled trial, 240 adults with prediabetes, 9 months; funding not stated on PubMed. PubMed 22773702.
45. Wai HS, et al. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. BMC Complementary Medicine and Therapies, 2025. Network meta-analysis, 17 trials; no competing interests declared. PubMed 40731001.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

This article is general information, not medical advice. Turmeric supplements interact with some prescription medicines and are not taken with gallstones or liver disease, or in pregnancy; ask your pharmacist first, and never stop or replace a prescribed medicine on the strength of a supplement.